Results 111 to 120 of about 798,328 (346)

Time to change to improve health: clinical pharmacy and pharmaceutical care education in Turkey

Journal of Ideas in Health, 2020
The practice of clinical pharmacy had a positive impact on the profession by giving pharmacists more job opportunities. Moreover, the pharmacy began to gain the status it deserved, which was lost many years ago.
Muhammed Yunus Bektay, Mesut Sancar, Saad Ahmed Ali Jadoo, Fikret Vehbi Izzettin   +3 more
doaj  

Reforms in pharmacy education and opportunity to practise clinical pharmacy [PDF]

, 1987
Arnold Birenbaum, Roslyn Wallach Bologh, Henry R. Lesieur   +2 more
openalex   +1 more source

European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’

International Journal of Clinical Pharmacy
All patients and members of the public should have access to high quality clinical pharmacy services, irrespective of country and setting. However, while the literature is awash with a plethora of studies which report small scale, pilot innovations in clinical pharmacy, there is a lack of studies which report these innovations being scaled across ...
Scott, Michael, Urbańczyk, Kamila, Stewart, Derek   +2 more
openaire   +4 more sources

Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives This ongoing, open‐label extension study is evaluating the long‐term safety, tolerability, and efficacy of givinostat, a Class I and II histone deacetylase inhibitor, in patients with Duchenne muscular dystrophy (DMD). Methods The recruited patients completed one of two prior clinical studies (one Phase 2 and one Phase 3 [EPIDYS ...
Craig M. McDonald, Michela Guglieri, Dragana Vučinić, Gyula Acsadi, John F. Brandsema, Claudio Bruno, Erika L. Finanger, Amy Harper, Mercedes Lopez Lobato, Riccardo Masson, Nuria Muelas, Francina Munell, Yoram Nevo, Yann Péréon, Han Phan, Valeria A. Sansone, Mariacristina Scoto, Tracey Willis, Richard S. Finkel, Krista Vandenborne, Sara Cazzaniga, Silvia Montrasio, Federica Alessi, Paolo Bettica, Eugenio Mercuri, for the Givinostat Study 51 Investigators, the Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study (DNHS) Investigators, the ImagingDMD Investigators, Enrico Bertini, Giacomo Pietro Comi, Eugenio Maria Mercuri, Giuseppe Vita, Sonia Messina, Claudio Bruno, Riccardo Masson, Valeria Sansone, Nathalie Goemans, Liesbeth De Waele, Laurent Servais, Teresa Gidaro, Odile Boespflug‐Tanguy, Yann Péréon, Jessika Johannsen, Astrid Blaschek, Ulrike Schara‐Schmidt, Erik Niks, Imelda de Groot, Saskia Houwen‐van Opstal, Andres Nascimento, Juan Jesus Vilchez, Nuria Muelas, Francina Munell, Marcos Madruga Garrido, Mercedes Lopez Lobato, Michaela Guglieri, Tracey Willis, Stefan Spinty, Daniel Hawcutt, Mariacristina Scoto, Jean K. Mah, Laura McAdam, Kathryn Selby, Katherine Mathews, Craig McDonald, Craig Zaidman, Barry Byrne, John Brandsema, Gyula Acsadi, Chamindra Laverty, Amy Harper, Erika Finanger, Han Phan, Yoram Nevo, Vedrana Milic Rasic, Dragana Vucinic   +74 more
wiley   +1 more source

Clinical Pharmacy–Specialty or General Direction? [PDF]

, 1986
George P. Provost
openalex   +1 more source

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang, Shenglan Li, Liang Wang, Qianxue Chen, Weiguo Hu, Ting Lei, Ying Mao, Jing Zhang, Xiaojun Xiang, Qiming Wang, Zhengwen He, Tao Sun, Yulei Wang, Mengqian Huang, Rong Zhang, Feng Chen, Wenbin Li   +16 more
wiley   +1 more source

Attitudes of Doctor of Pharmacy Students Toward the Application of Social and Administrative Pharmacy in Clinical Practice [PDF]

, 1978
Over the past decade, dramatic changes have occurred in the education of pharmacists. A significant factor in this change has been the introduction of clinical pharmacy.
Bootman, J. Lyle, Johnson, C. Anderson
core   +2 more sources

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin, Gregory Sahagian, Marc H. Feinberg, C. Andrew Stewart, Christopher M. Jewell, Metin Kurtoglu, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard Jr, the MG‐001 Study Group   +10 more
wiley   +1 more source

Ethical Issues Related to Clinical Pharmacy Research [PDF]

, 1993
David Rutledge, Clinton Stewart, Daniel P. Wermeling, Kathryn Blake, Jacqueline Danyluk, Jimmi Hatton, Dennis K. Helling, DALE K. HOOKER, David Knoppert, Patrick Pharm, Christopher Mccollam, Michael Paap, Kathleen A. Stringer, Joseph T. DiPiro, Toni Sumpter   +14 more
openalex   +1 more source

Pharmacy and Clinical Pharmacy [PDF]

Drug Intelligence & Clinical Pharmacy, 1971
openaire   +2 more sources